LEADER 00992nam--2200349---450- 001 990001087380203316 005 20020711111004.0 010 $a88-14-09419-5 035 $a000108738 035 $aUSA01000108738 035 $a(ALEPH)000108738USA01 035 $a000108738 100 $a20020711d2002----km-y0itay0103----ba 101 $aita 102 $aIT 105 $ay|||z|||001yy 200 1 $aDiritto tributario$eparte speciale$ei sistemi dei singoli tributi$fRaffaello Lupi 205 $a7. ed. 210 $aMilano$cA.Giuffré$dcopyr.2002 215 $aXX, 392 p.$d24 cm 606 0$aDiritto tributario 676 $a343.4504 700 1$aLUPI,$bRaffaello$0132980 801 0$aIT$bsalbc$gISBD 912 $a990001087380203316 951 $aIG VII 424 d SPEC$b33388 G.$cIG VII$d00082279 959 $aBK 969 $aGIU 979 $aPAOLA$b90$c20020711$lUSA01$h1110 979 $aPATRY$b90$c20040406$lUSA01$h1715 996 $aDiritto tributario$937706 997 $aUNISA LEADER 03214nas 2200685- 450 001 9910267959803321 005 20230123213018.0 011 $a2531-1387 035 $a(OCoLC)1030844748 035 $a(CKB)4100000002589216 035 $a(CONSER)--2018243218 035 $a(NjHacI)994100000002589216 035 $a(DE-599)ZDB2945333-1 035 $a(EXLCZ)994100000002589216 100 $a20180329a20189999 o-- - 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aHematology, transfusion and cell therapy 210 1$a[Sa?o Paulo, Brazil]$cAssociação Brasileira de Hematologia, Hemoterapia e Terapia Celular,$d2018- 210 3$a[Amsterdam] :$cElsevier Editora Ltda ;$c,$d2018- 215 $a1 online resource 300 $aRefereed/Peer-reviewed 311 08$a2531-1379 327 $aHaemoglobinopathies from the cardiac point of view -- Comment to: Test seeking: are health care professionals referring people to the blood centers for infectious markers testing? -- Hepatitis B virus infection among oncohematologic disease patients in Central Brazil: prevalence, risk factors and immunization -- CD9 predicts ETV6-RUNX1 in childhood B-cell precursor acute lymphoblastic leukemia -- Incidence and spatial distribution of Chronic Myeloid Leukemia by regions of economic development in the state of Pernambuco, Brazil -- Iron deficiency, still a rarity in children with sickle cell anemia in Ile-Ife, Nigeria -- What happens to intolerant, relapsed or refractory chronic myeloid leukemia patients without access to clinical trials? -- Test seeking: are healthcare professionals referring people to blood centers for infections marker testing? -- Marrow iron staining should always be performed to diagnose Myelodysplastic/myeloproliferative neoplasia with ring sideroblasts and thrombocythemia. 531 $aHEMATOL TRANSFUS CELL THER 531 10$aHematol Transfus Cell Ther 606 $aHematology$vPeriodicals 606 $aBlood$xTransfusion$vPeriodicals 606 $aBlood Transfusion 606 $aBone Marrow Transplantation 606 $aBlood$xTransfusion$2fast$3(OCoLC)fst00834613 606 $aHematology$2fast$3(OCoLC)fst00954904 606 $aHematologic Diseases 607 $aBrazil 608 $aPeriodical. 608 $aFulltext. 608 $aInternet Resources. 608 $aPeriodicals.$2fast 608 $aPeriodicals. 615 0$aHematology 615 0$aBlood$xTransfusion 615 22$aBlood Transfusion. 615 22$aBone Marrow Transplantation. 615 7$aBlood$xTransfusion. 615 7$aHematology. 615 12$aHematologic Diseases. 676 $a616.15 712 02$aAssociação Brasileira de Hematologia, Hemoterapia e Terapia Celular, 712 02$aSociedade Brasileira de Transplante de Medula Ossea, 712 02$aAssociazione Italo-Brasiliana di Ematologia, 712 02$aSociedade Brasileira de Oncologia Pediátrica, 801 0$bNjHacI 801 1$bNjHacI 906 $aJOURNAL 912 $a9910267959803321 996 $aHematology, transfusion and cell therapy$91897665 997 $aUNINA